Paclitaxel for Injection (Albumin-bound)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Paclitaxel for Injection (Albumin-bound), covering 2020-05-28 to 2025-05-08. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type) [Phase 2]